Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Quarterly Sales
Pharma
As vaccine sales declined in Q3, Lilly thrived with 54% growth
The commercial effects of an emboldened anti-vaccine movement in the U.S. were evident in Q3 as several companies reported declining vaccine sales.
Kevin Dunleavy
Nov 24, 2025 3:00am
Amgen CEO critiques FDA push to reform biosimilars market
Nov 5, 2025 8:31am
As Vertex's pain launch gains more use, sales just missed in Q3
Nov 4, 2025 8:40am
Sarepta, despite key trial flop, will seek full nod for DMD meds
Nov 4, 2025 7:56am
AbbVie increases 2025 revenue projection again, now at $60.9B
Oct 31, 2025 12:14pm
Cobenfy delivers OK debut year as BMS works to ease nerves
Oct 30, 2025 11:19am
